Sotera Health Future Growth
Future criteria checks 4/6
Sotera Health is forecast to grow earnings and revenue by 38.3% and 5.9% per annum respectively. EPS is expected to grow by 37.7% per annum. Return on equity is forecast to be 37.5% in 3 years.
Key information
38.3%
Earnings growth rate
37.7%
EPS growth rate
| Life Sciences earnings growth | 16.8% |
| Revenue growth rate | 5.9% |
| Future return on equity | 37.5% |
| Analyst coverage | Good |
| Last updated | 21 May 2024 |
Recent future growth updates
Recent updates
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%
Mar 21
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models
Mar 01McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount
Feb 08Is Sotera Health (NASDAQ:SHC) A Risky Investment?
Feb 06Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump
Dec 28Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price
Dec 11An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued
Sep 10Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jun 05Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?
Feb 13Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher
Nov 24Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit
Sep 19Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?
Sep 08Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M
Aug 04Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?
May 09Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)
Mar 16Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?
Jan 19A Look At The Fair Value Of Sotera Health Company (NASDAQ:SHC)
Sep 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,263 | 173 | 301 | N/A | 3 |
| 12/31/2025 | 1,177 | 137 | 278 | 309 | 7 |
| 12/31/2024 | 1,102 | 92 | 207 | 252 | 7 |
| 3/31/2024 | 1,077 | 55 | -377 | -172 | N/A |
| 12/31/2023 | 1,049 | 51 | -363 | -148 | N/A |
| 9/30/2023 | 991 | -306 | -381 | -159 | N/A |
| 6/30/2023 | 976 | -268 | -342 | -133 | N/A |
| 3/31/2023 | 988 | -261 | 70 | 262 | N/A |
| 12/31/2022 | 1,004 | -234 | 96 | 278 | N/A |
| 9/30/2022 | 993 | 121 | 90 | 242 | N/A |
| 6/30/2022 | 971 | 123 | 127 | 256 | N/A |
| 3/31/2022 | 956 | 135 | 159 | 275 | N/A |
| 12/31/2021 | 931 | 115 | 179 | 282 | N/A |
| 9/30/2021 | 907 | 36 | 156 | 237 | N/A |
| 6/30/2021 | 881 | 9 | 127 | 202 | N/A |
| 3/31/2021 | 842 | -26 | 110 | 171 | N/A |
| 12/31/2020 | 818 | -39 | 67 | 121 | N/A |
| 9/30/2020 | 795 | -23 | 55 | 109 | N/A |
| 6/30/2020 | 790 | -28 | 68 | 124 | N/A |
| 3/31/2020 | 772 | -29 | 58 | 116 | N/A |
| 12/31/2019 | 778 | -21 | 92 | 149 | N/A |
| 12/31/2018 | 746 | -6 | 47 | 120 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHC's forecast earnings growth (38.3% per year) is above the savings rate (2.4%).
Earnings vs Market: SHC's earnings (38.3% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: SHC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SHC's revenue (5.9% per year) is forecast to grow slower than the US market (8.4% per year).
High Growth Revenue: SHC's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHC's Return on Equity is forecast to be high in 3 years time (37.5%)